Evidence map›Paper›PMID 26055716›Full record

ArticleThe Journal of biological chemistry2015

Rkr1/Ltn1 Ubiquitin Ligase-mediated Degradation of Translationally Stalled Endoplasmic Reticulum Proteins.

Justin J Crowder, Marco Geigges, Ryan T Gibson, Eric S Fults, Bryce W Buchanan, Nadine Sachs, Andrea Schink, Stefan G Kreft, Eric M Rubenstein

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Phenomic and Transcriptomic Profiling of ZnS QD Response inNanomaterials (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Quality control and signaling pathways at stalled ribosomes.Experimental & molecular medicine · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. RPL26/uL24 UFMylation is essential for ribosome-associated quality control at the endoplasmic reticulum.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. APC/CmicroPublication biology · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Justin J CrowderFrom the Department of Biology, Ball State University, Muncie, Indiana 47306 and.
Marco Geiggesthe Department of Biology, University of Konstanz, 78457 Konstanz, Germany.
Ryan T GibsonFrom the Department of Biology, Ball State University, Muncie, Indiana 47306 and.
Eric S FultsFrom the Department of Biology, Ball State University, Muncie, Indiana 47306 and.
Bryce W BuchananFrom the Department of Biology, Ball State University, Muncie, Indiana 47306 and.
Nadine Sachsthe Department of Biology, University of Konstanz, 78457 Konstanz, Germany.
Andrea Schinkthe Department of Biology, University of Konstanz, 78457 Konstanz, Germany.
Stefan G Kreftthe Department of Biology, University of Konstanz, 78457 Konstanz, Germany stefan.kreft@uni-konstanz.de.
Eric M RubensteinFrom the Department of Biology, Ball State University, Muncie, Indiana 47306 and emrubenstein@bsu.edu.
Ball State University · USUniversity of Konstanz · DE

Funding

Regulation of Endoplasmic Reticulum Protein Quality Control by Microtubule-Associated ProteinsR15GM111713 · NIGMS · BALL STATE UNIVERSITY · PI Eric Meyer Rubenstein · 2014 to 2026
$1.8M
NIGMS NIH HHS R15 GM111713
6 · The paper itself

Abstract

Aberrant nonstop proteins arise from translation of mRNA molecules beyond the coding sequence into the 3'-untranslated region. If a stop codon is not encountered, translation continues into the poly(A) tail, resulting in C-terminal appendage of a polylysine tract and a terminally stalled ribosome. In Saccharomyces cerevisiae, the ubiquitin ligase Rkr1/Ltn1 has been implicated in the proteasomal degradation of soluble cytosolic nonstop and translationally stalled proteins. Rkr1 is essential for cellular fitness under conditions associated with increased prevalence of nonstop proteins. Mutation of the mammalian homolog causes significant neurological pathology, suggesting broad physiological significance of ribosome-associated quality control. It is not known whether and how soluble or transmembrane nonstop and translationally stalled proteins targeted to the endoplasmic reticulum (ER) are detected and degraded. We generated and characterized model soluble and transmembrane ER-targeted nonstop and translationally stalled proteins. We found that these proteins are indeed subject to proteasomal degradation. We tested three candidate ubiquitin ligases (Rkr1 and ER-associated Doa10 and Hrd1) for roles in regulating abundance of these proteins. Our results indicate that Rkr1 plays the primary role in targeting the tested model ER-targeted nonstop and translationally stalled proteins for degradation. These data expand the catalog of Rkr1 substrates and highlight a previously unappreciated role for this ubiquitin ligase at the ER membrane.

Indexed as

Protein BiosynthesisAnimalsEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationProteolysisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinUbiquitinationUbiquitin-Protein LigasesRkr1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinUbiquitin-Protein LigasesE3 ubiquitin ligaseendoplasmic reticulum-associated protein degradation (ERAD)ER quality controlprotein translocationribosomeribosome-associated degradationSaccharomyces cerevisiaetranslationyeast genetics

Identifiers

PMID26055716
PMCPMC4513105
OpenAlexW2215693801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.